# FDA 483 - Bio-Medical Pharmaceutical Manufacturing Corporation - January 23, 2020

Source: https://www.globalkeysolutions.net/records/483/bio-medical-pharmaceutical-manufacturing-corporation/c33d89af-4d4c-44bc-81ac-912d40d13f26

> FDA 483 for Bio-Medical Pharmaceutical Manufacturing Corporation on January 23, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Bio-Medical Pharmaceutical Manufacturing Corporation
- Inspection Date: 2020-01-23
- Product Type: drugs
- Office Name: Dallas District Office
- Summary: Bio Medical & Pharmaceutical Manufacturing Corp. in Houston, TX, was inspected regarding its drug product manufacturing operations. The inspection revealed significant deficiencies, including failure to follow written cleaning procedures, inadequate CGMP training for employees, and poor maintenance of equipment calibration records. These issues indicate a lack of adherence to current Good Manufacturing Practices.

## Related Documents

- [483 - 2025-08-29](https://www.globalkeysolutions.net/records/483/bio-medical-pharmaceutical-manufacturing-corporation/2c576cf8-6559-4b8f-9bc3-66e403329073)
- [WARNING_LETTER - 2025-08-29](https://www.globalkeysolutions.net/records/warning_letter/bio-medical-pharmaceutical-manufacturing-corporation/c3f49883-6cdd-4757-8d03-40ec8016fdd0)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/shatina-r-alridge/f4715fcf-fb27-4ef3-8289-adfff2db62bf)

Company: https://www.globalkeysolutions.net/companies/bio-medical-pharmaceutical-manufacturing-corporation/ff03af78-b7e9-4d7f-97ba-78089c6ee119

Office: https://www.globalkeysolutions.net/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9